Bio-Rad Lyme Assay FDA Cleared
Apr 3, 2019 @ 11:03

The addition of the BioPlex 2200 Lyme Total assay broadens our BioPlex 2200 System infectious disease menu, offering laboratories the ability to detect Lyme disease at an early stage and thus fulfilling an important medical need in the management of Lyme disease," said John Hertia, president of Bio-Rad’s clinical diagnostics group.

Sourced through from:

Leave a Reply